Gainers
- Biomea Fusion (NASDAQ:BMEA) shares rose 60.7% to $24.79 during Tuesday's pre-market session. The company's market cap stands at $728.7 million.
- Biodexa Pharmaceuticals (NASDAQ:BDRX) stock moved upwards by 54.7% to $0.73. The company's market cap stands at $5.0 million.
- Viking Therapeutics (NASDAQ:VKTX) stock increased by 36.73% to $12.47. The company's market cap stands at $977.8 million.
- Accelerate Diagnostics (NASDAQ:AXDX) shares increased by 15.99% to $0.58. The company's market cap stands at $57.4 million.
- Addex Therapeutics (NASDAQ:ADXN) shares rose 14.81% to $1.24. The company's market cap stands at $23.8 million.
- Intra-Cellular Therapies (NASDAQ:ITCI) shares moved upwards by 14.45% to $54.8. The company's market cap stands at $5.2 billion.
Losers
- Monopar Therapeutics (NASDAQ:MNPR) stock declined by 49.0% to $1.52 during Tuesday's pre-market session. The market value of their outstanding shares is at $20.0 million. As per the news, the Q4 earnings report came out 3 days ago.
- NexGel (NASDAQ:NXGL) shares fell 29.24% to $1.15. The company's market cap stands at $6.4 million. As per the press release, Q4 earnings came out yesterday.
- OncoSec Medical (NASDAQ:ONCS) stock decreased by 24.25% to $2.0. The market value of their outstanding shares is at $5.9 million.
- Trxade Health (NASDAQ:MEDS) stock decreased by 20.88% to $0.36. The company's market cap stands at $3.3 million. As per the news, the Q4 earnings report came out yesterday.
- TC BioPharm (Holdings) (NASDAQ:TCBP) stock decreased by 19.66% to $1.41. The market value of their outstanding shares is at $3.1 million.
- Harmony Biosciences (NASDAQ:HRMY) shares declined by 19.26% to $33.51. The market value of their outstanding shares is at $1.9 billion. See Also:
This article was generated by Benzinga's automated content engine and reviewed by an editor.